Eian Kantor

How to read a clinical trial listing using Antidote’s matching tool

If you’re interested in joining a clinical trial, one of the first places anyone will tell you to look is ClinicalTrials.gov, a database of privately and publicly funded clinical studies conducted around the world. Everyone has access to the key details of clinical trials listed on ClinicalTrials.gov, where you can see eligibility criteria. However, inclusion and exclusion criteria have become ...

Continue reading

5 ways technology can improve clinical trial patient recruitment

Are you facing clinical trial patient recruitment challenges? Technology can help. There are many digital solutions that improve the recruitment process, from finding patients to prescreening and enrolling them into trials. Consider these helpful ways technology can improve the patient experience and accelerate enrollment into your trial, and take a look at our list of clinical trial patient ...

Continue reading

What is peripheral artery disease and where can you find support?

Peripheral artery disease (PAD) is a narrowing or blockage of the vessels (peripheral arteries) that carry blood away from the heart to other parts of the body. The most common form of PAD reduces blood flow from the heart to the legs and feet. PAD is primarily caused by atherosclerosis, which is the buildup of fatty plaque in the arteries that narrows and blocks them in the heart, brain, arms, ...

Continue reading

Talk of the Towne podcast episode 02: Lupus Therapeutics

Antidote’s new podcast, Talk of the Towne, focuses on the ultimate sweet spot: that special place where science and patients converge. Our host, Rich Towne, was trained in pharmacy and currently works in Clinical Informatics at Antidote. In each episode, Rich welcomes a new guest from an organization with which Antidote is working, and takes an in-depth look at particular therapeutic areas, ...

Continue reading

The wrong way to use social media for clinical trial recruitment

Sometimes pharma professionals and researchers tell us that they didn't get the results they wanted from using social media for clinical trial recruitment. Patients responded to ads, they say, but didn't end up taking the next step. We've also heard that their social media referrals weren't ultimately eligible for the trial or that they lived too far from research sites. Then there's the concern ...

Continue reading

What does life after a stroke look like?

A stroke is an event that affects the arteries of the brain. When a blood vessel that brings blood to the brain gets blocked or bursts, a stroke occurs. The area of the brain impacted by a stroke can’t get the nutrients and oxygen it needs, causing nerve cells to lose their functionality.

Continue reading

Questions to ask when considering rescuing a trial [checklist]

A clinical trial rescue is one that, for any number of reasons, is not meeting expectations and requires a “reboot.” The trial may need to be accelerated or may need process failures corrected.

Continue reading

What is Duchenne muscular dystrophy and where do you find support?

Duchenne muscular dystrophy (also referred to simply as “Duchenne”) is a rare genetic disorder characterized by a progressive loss of muscle due to alterations of dystrophin, a protein that helps keep muscles intact. When dystrophin is altered or absent, muscles are not able to function properly.

Continue reading

How clinical trial recruitment companies can improve study timelines

More than 80% of clinical trials don't reach their recruitment deadlines. Accelerating patient recruitment can allow your trial to beat deadlines and bring your treatment to market faster. Speeding up timelines is easier said than done, though. Working with a clinical trial patient recruitment company that takes care of some of the most challenging parts of recruitment, including prescreening ...

Continue reading

How to treat primary biliary cholangitis and where to find support

Primary biliary cholangitis (PBC) is a chronic autoimmune disease. Researchers estimate that about 65 out of every 100,000 women in the United States have PBC (this number is much lower in men). When a person has PBC, the immune system attacks the small bile ducts, which can cause damage to the liver.

Continue reading

Get our latest posts in your inbox